These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17555469)

  • 1. The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction.
    Stass H; Bührmann S; Mitchell A; Kubitza D; Möller JG; Kribben A; Wenzel RR; Schäfers RF
    Br J Clin Pharmacol; 2007 Dec; 64(6):745-9. PubMed ID: 17555469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Ahmed S; Thalhammer F
    J Antimicrob Chemother; 2004 Oct; 54(4):780-4. PubMed ID: 15347636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment.
    Barth J; Jäger D; Mundkowski R; Drewelow B; Welte T; Burkhardt O
    J Antimicrob Chemother; 2008 Sep; 62(3):575-8. PubMed ID: 18515790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of moxifloxacin in critically ill patients with impaired renal function undergoing pulse high-volume haemofiltration.
    Zhang L; Li L; Shi W; Liu S; Liang X; Ye Z; Wang WJ; Zhang B; Li R; Chen Y; Yu C; Zhuo L; Wang X
    Int J Antimicrob Agents; 2013 Sep; 42(3):244-9. PubMed ID: 23876335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H; Kubitza D; Möller JG; Delesen H
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
    Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery.
    De Smet J; Colin P; De Paepe P; Ruige J; Batens H; Van Nieuwenhove Y; Vogelaers D; Blot S; Van Bocxlaer J; Van Bortel LM; Boussery K
    J Antimicrob Chemother; 2012 Jan; 67(1):226-9. PubMed ID: 21987240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
    Breilh D; Jougon J; Djabarouti S; Gordien JB; Xuereb F; Velly JF; Arvis P; Landreau V; Saux MC
    J Chemother; 2003 Dec; 15(6):558-62. PubMed ID: 14998080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers.
    Wagenlehner FM; Kees F; Weidner W; Wagenlehner C; Naber KG
    Int J Antimicrob Agents; 2008 Jan; 31(1):21-6. PubMed ID: 18054465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations and pharmacokinetics of moxifloxacin in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
    Wiesner G; Martin K; Gertler R; Braun SL; Tassani P; Lange R; Gruber M
    Int J Antimicrob Agents; 2013 May; 41(5):473-6. PubMed ID: 23481660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.
    Kees MG; Weber S; Kees F; Horbach T
    J Antimicrob Chemother; 2011 Oct; 66(10):2330-5. PubMed ID: 21729931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration.
    Fernández-Varón E; Bovaira MJ; Espuny A; Escudero E; Vancraeynest D; Cárceles CM
    J Vet Pharmacol Ther; 2005 Aug; 28(4):343-8. PubMed ID: 16050813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of moxifloxacin are not influenced by a 7-day pretreatment with 200 mg oral itraconazole given once a day in healthy subjects.
    Stass H; Nagelschmitz J; Moeller JG; Delesen H
    Int J Clin Pharmacol Ther; 2004 Jan; 42(1):23-9. PubMed ID: 14756383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.
    Wacke R; Förster S; Adam U; Mundkowski RG; Klar E; Hopt UT; Drewelow B
    J Antimicrob Chemother; 2006 Nov; 58(5):994-9. PubMed ID: 16956903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep.
    Cárceles CM; Escudero E; Fernández-Varón E; Marín P
    Vet J; 2009 Jun; 180(3):343-7. PubMed ID: 18406644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration.
    Goudah A; Hasabelnaby S
    Res Vet Sci; 2010 Jun; 88(3):507-11. PubMed ID: 20004428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H; Rink AD; Delesen H; Kubitza D; Vestweber KH
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro.
    Ittner KP; Roth G; Gruber M; Pawlik M; Taeger K
    J Antimicrob Chemother; 2005 Aug; 56(2):360-4. PubMed ID: 15983025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats.
    Fernández-Varón E; Villamayor L; Escudero E; Espuny A; Cárceles CM
    Vet J; 2006 Sep; 172(2):302-7. PubMed ID: 15908243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.